{"id":1042213,"date":"2012-10-21T07:44:15","date_gmt":"2012-10-21T07:44:15","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/longevity-medicine\/research-and-markets-multiple-sclerosis-pipeline-review-h2-2012.php"},"modified":"2024-08-17T16:55:32","modified_gmt":"2024-08-17T20:55:32","slug":"research-and-markets-multiple-sclerosis-pipeline-review-h2-2012","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity-medicine\/research-and-markets-multiple-sclerosis-pipeline-review-h2-2012.php","title":{"rendered":"Research and Markets: Multiple Sclerosis \u2013 Pipeline Review, H2 2012"},"content":{"rendered":"<p><p>    DUBLIN&#8211;(BUSINESS WIRE)&#8211;  <\/p>\n<p>    Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/q5j88n\/multiple\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/q5j88n\/multiple<\/a>)    has announced the addition of Global Markets Direct&#8217;s new    report &#8220;Multiple Sclerosis &#8211; Pipeline Review, H2 2012&#8243; to their    offering.  <\/p>\n<p>    Global Markets Direct&#8217;s, &#8216;Multiple Sclerosis &#8211; Pipeline Review,    Global Markets Direct&#8217;s, &#8216;Multiple Sclerosis &#8211; Pipeline Review,    H2 2012&#8242;, provides an overview of the indication&#8217;s therapeutic    pipeline. This report provides information on the therapeutic    development for Multiple Sclerosis, complete with latest    updates, and special features on late-stage and discontinued    projects. It also reviews key players involved in the    therapeutic development for Multiple Sclerosis. Multiple    Sclerosis &#8211; Pipeline Review, Half Year is built using data and    information sourced from Global Markets Direct&#8217;s proprietary    databases, Company\/University websites, SEC filings, investor    presentations and featured press releases from    company\/university sites and industry-specific third party    sources, put together by Global Markets Direct&#8217;s team.  <\/p>\n<p>    Scope  <\/p>\n<p>    &#8211; A snapshot of the global therapeutic scenario for Multiple    Sclerosis.  <\/p>\n<p>    &#8211; A review of the Multiple Sclerosis products under development    by companies and universities\/research institutes based on    information derived from company and industry-specific sources.  <\/p>\n<p>    &#8211; Coverage of products based on various stages of development    ranging from discovery till registration stages.  <\/p>\n<p>    &#8211; A feature on pipeline projects on the basis of monotherapy    and combined therapeutics.  <\/p>\n<p>    &#8211; Coverage of the Multiple Sclerosis pipeline on the basis of    route of administration and molecule type.  <\/p>\n<p>    &#8211; Key discontinued pipeline projects.  <\/p>\n<\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/research-markets-multiple-sclerosis-pipeline-132400103.html;_ylt=A2KJ3Cbex39Q2CAABjj_wgt.\" title=\"Research and Markets: Multiple Sclerosis - Pipeline Review, H2 2012\" rel=\"noopener\">Research and Markets: Multiple Sclerosis &#8211; Pipeline Review, H2 2012<\/a><\/p>\n<p>Source:<br \/><a href=\"http:\/\/www.longevitymedicine.tv\/research-and-markets-multiple-sclerosis-pipeline-review-h2-2012\/\">http:\/\/www.longevitymedicine.tv\/research-and-markets-multiple-sclerosis-pipeline-review-h2-2012\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211; Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/q5j88n\/multiple\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/q5j88n\/multiple<\/a>) has announced the addition of Global Markets Direct&#8217;s new report &#8220;Multiple Sclerosis &#8211; Pipeline Review, H2 2012&#8243; to their offering. Global Markets Direct&#8217;s, &#8216;Multiple Sclerosis &#8211; Pipeline Review, Global Markets Direct&#8217;s, &#8216;Multiple Sclerosis &#8211; &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity-medicine\/research-and-markets-multiple-sclerosis-pipeline-review-h2-2012.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246678],"tags":[],"class_list":["post-1042213","post","type-post","status-publish","format-standard","hentry","category-longevity-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1042213"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1042213"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1042213\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1042213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1042213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1042213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}